Anson Funds Management LP lowered its stake in shares of Liquidia Co. (NASDAQ:LQDA - Free Report) by 70.9% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 51,403 shares of the company's stock after selling 125,000 shares during the quarter. Anson Funds Management LP owned approximately 0.06% of Liquidia worth $604,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in LQDA. Vanguard Group Inc. raised its stake in shares of Liquidia by 3.4% in the fourth quarter. Vanguard Group Inc. now owns 3,557,296 shares of the company's stock valued at $41,834,000 after buying an additional 115,367 shares during the period. LM Advisors LLC purchased a new position in shares of Liquidia in the fourth quarter worth about $25,948,000. Geode Capital Management LLC raised its position in shares of Liquidia by 8.2% in the fourth quarter. Geode Capital Management LLC now owns 1,339,254 shares of the company's stock valued at $15,753,000 after purchasing an additional 101,597 shares during the period. Invesco Ltd. raised its position in shares of Liquidia by 2,675.0% in the fourth quarter. Invesco Ltd. now owns 700,171 shares of the company's stock valued at $8,234,000 after purchasing an additional 674,940 shares during the period. Finally, Northern Trust Corp lifted its stake in shares of Liquidia by 19.5% during the 4th quarter. Northern Trust Corp now owns 589,921 shares of the company's stock valued at $6,937,000 after buying an additional 96,381 shares in the last quarter. 64.54% of the stock is currently owned by hedge funds and other institutional investors.
Liquidia Stock Performance
NASDAQ:LQDA traded down $0.01 during mid-day trading on Wednesday, reaching $15.53. The stock had a trading volume of 1,156,365 shares, compared to its average volume of 1,037,618. Liquidia Co. has a one year low of $8.26 and a one year high of $16.81. The firm has a 50 day moving average price of $14.24 and a two-hundred day moving average price of $13.07. The stock has a market capitalization of $1.33 billion, a P/E ratio of -9.53 and a beta of 0.24.
Liquidia (NASDAQ:LQDA - Get Free Report) last released its earnings results on Wednesday, March 19th. The company reported ($0.46) EPS for the quarter, missing the consensus estimate of ($0.38) by ($0.08). Liquidia had a negative net margin of 765.38% and a negative return on equity of 163.21%. The business had revenue of $2.92 million for the quarter, compared to the consensus estimate of $4.60 million. Research analysts forecast that Liquidia Co. will post -1.51 earnings per share for the current year.
Wall Street Analyst Weigh In
Several research firms have issued reports on LQDA. Scotiabank increased their target price on Liquidia from $34.00 to $36.00 and gave the stock a "sector outperform" rating in a research report on Monday. HC Wainwright restated a "buy" rating and issued a $29.00 target price on shares of Liquidia in a research note on Thursday, March 20th. Finally, Needham & Company LLC reiterated a "buy" rating and set a $25.00 price target on shares of Liquidia in a research report on Thursday, April 10th. One investment analyst has rated the stock with a hold rating, six have assigned a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the stock has an average rating of "Buy" and a consensus target price of $26.88.
Check Out Our Latest Analysis on LQDA
Insider Activity at Liquidia
In other news, insider Rajeev Saggar sold 2,450 shares of the stock in a transaction that occurred on Monday, April 21st. The stock was sold at an average price of $13.67, for a total value of $33,491.50. Following the completion of the transaction, the insider now owns 263,152 shares of the company's stock, valued at approximately $3,597,287.84. This represents a 0.92 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, General Counsel Russell Schundler sold 5,964 shares of Liquidia stock in a transaction that occurred on Monday, April 14th. The shares were sold at an average price of $13.57, for a total value of $80,931.48. Following the sale, the general counsel now owns 570,301 shares in the company, valued at $7,738,984.57. This represents a 1.03 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 33,138 shares of company stock worth $450,233 in the last three months. 30.10% of the stock is owned by insiders.
About Liquidia
(
Free Report)
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).
See Also
Before you consider Liquidia, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Liquidia wasn't on the list.
While Liquidia currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
